ScholarIQanswers from OpenAlex & ORCID
Judith M. Bliss
ResearcherPublications, citations & collaboration network
Judith M. Bliss is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Judith M. Bliss have?
ScholarIQindexed works
Judith M. Bliss has 806 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Judith M. Bliss have?
ScholarIQcitation count
Judith M. Bliss has 39,430 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Judith M. Bliss?
ScholarIQh-index
Judith M. Bliss has an h-index of 91 in OpenAlex.
What is the i10-index of Judith M. Bliss?
ScholarIQi10-index
Judith M. Bliss has an i10-index of 244 in OpenAlex.
What is the ORCID of Judith M. Bliss?
ScholarIQorcid
The ORCID for Judith M. Bliss is on the source record.
What is the OpenAlex record for Judith M. Bliss?
ScholarIQopenalex
The OpenAlex for Judith M. Bliss is on the source record.
What are the most-cited papers on Judith M. Bliss?
ScholarIQmost cited works
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
R. Charles Coombes, Emma Hall, Lorna J. Gibson, Robert Paridaens, Jacek Jassem, T. Delozier, Stephen E. Jones, Isabel Álvarez, Gianfilippo Bertelli, Olaf Ortmann, Alan S. Coates, Emilio Bajetta, David Dodwell, Robert E. Coleman, Lesley Fallowfield, E. Mickiewicz, Jørn Andersen, Per Eystein Lønning, Giorgio Cocconi, Alan L. Stewart, Nick Stuart, Claire Snowdon, M. Carpentieri, Giorgio Massimini, Judith M. Bliss
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt, Joanne Haviland, Duncan Wheatley, Mark Sydenham, Abdulla Alhasso, David Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E. Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M. Kirby, Cliona Kirwan, Carolyn Morris, Zohal Nabi, Elinor J. Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M. Bliss, John Yarnold, Abdulla Alhasso, Anne Armstrong, Judith M. Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Charlie Chan, H. Chantler, Mark Churn, Susan Cleator, Charlotte E. Coles, Ellen M. Donovan, Andy Goodman, Susan Griffin, Joanne Haviland, P. Hopwood, Anna M. Kirby, Julie Kirk, Cliona Kirwan, Marjory Maclennan, Carolyn Morris, Zohal Nabi, Elinor J. Sawyer, Mark Sculphur, Judith Sinclair, Navita Somaiah, Liba Stones, Mark Sydenham, Isabel Syndikus, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R. Charles Coombes, Lucy Kilburn, CF Snowdon, Robert Paridaens, RE Coleman, SE Jones, Jacek Jassem, CJH van de Velde, T. Delozier, Isabel Álvarez, Lucia Del Mastro, Olaf Ortmann, K. Diedrich, AS Coates, Emilio Bajetta, Holmberg Sb, David Dodwell, E. Mickiewicz, J. Andersen, Per Eystein Lønning, Giorgio Cocconi, John Forbes, M. Castiglione, N Stuart, A. Stewart, Lesley Fallowfield, Gianfilippo Bertelli, Emma Hall, Richard Bogle, M. Carpentieri, E Colajori, Milayna Subar, Elizabeth Ireland, Judith M. Bliss
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt, Holly Tovey, Maggie C.U. Cheang, Sarah Kernaghan, Lucy Kilburn, Patrycja Gazińska, Julie Owen, Jacinta Abraham, Sophie Barrett, Peter Barrett‐Lee, Robert Brown, Stephen Chan, Mitch Dowsett, James M. Flanagan, Lisa Fox, Anita Grigoriadis, Alexander Gutin, Catherine Harper‐Wynne, M. Hatton, Katherine A. Hoadley, Jyoti Parikh, Peter J. Parker, Charles M. Perou, Rebecca Roylance, Vandna Shah, Adam Shaw, Ian E. Smith, Kirsten M. Timms, Andrew Wardley, G. Wilson, Cheryl Gillett, Jerry S. Lanchbury, Alan Ashworth, Nazneen Rahman, Mark Harries, Paul Ellis, Sarah E. Pinder, Judith M. Bliss